A population based surveillance study to estimate the prevalence of cardiometabolic diseases (such as cardiovascular diseases, diabetes, chronic kidney diseases and stroke) and their risk factors (such as hypertension, obesity, diet, physical activity, stress, tobacco, alcohol, etc.).
Not Applicable
- Conditions
- Health Condition 1: null- Cardiometabolic Diseases such as Cardiovascular Diseases, Type II Diabetes, Stroke, Hypertension, Chronic Kidney DiseasesHealth Condition 2: I639- Cerebral infarction, unspecifiedHealth Condition 3: N189- Chronic kidney disease, unspecifiedHealth Condition 4: I10- Essential (primary) hypertensionHealth Condition 5: I519- Heart disease, unspecifiedHealth Condition 6: E118- Type 2 diabetes mellitus with unspecified complications
- Registration Number
- CTRI/2010/091/000440
- Lead Sponsor
- ational Heart Lung and Blood Institute NHLBI under the National Institutes of Health NIH USA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adults aged 20 years and more living in the urban areas of Delhi and Chennai
Exclusion Criteria
Pregnant women and bed-ridden individuals
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Through piloting this cohort-modeled community-based surveillance plan and capturing broad-ranging data (including underlying lifestyle habits and risk factors, incident events and target organ damage, morbidity and mortality, as well as qualitative themes such as quality of life, health-seeking behaviors, health care utilization, cost of care, and quality of care delivery), we hope to underscore:<br>8<br>a. The need to overlay these pilot studies with sustained, efficient measurement systems for key cardiometabolic disease determinants and outcomes at sentinel sites with a view to examining trends over time, and<br>b. The importance, feasibility, and benefits of maintaining and eventually expanding this initial surveillance infrastructure at other selected sites around the country, with gradual maturation to comprehensive data systems.Timepoint:
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI